179 related articles for article (PubMed ID: 26715293)
21. Bacteriology and treatment of malodorous lower reproductive tract in gynecologic cancer patients.
Von Gruenigen VE; Coleman RL; Li AJ; Heard MC; Miller DS; Hemsell DL
Obstet Gynecol; 2000 Jul; 96(1):23-7. PubMed ID: 10862836
[TBL] [Abstract][Full Text] [Related]
22. Comparison of once-daily and twice-daily dosing of 0.75% metronidazole gel in the treatment of bacterial vaginosis.
Livengood CH; Soper DE; Sheehan KL; Fenner DE; Martens MG; Nelson AL; Ismail M; Thorp JM; Lappin M; Long BJ; Blackwelder T; Sweet RL; Sagov S
Sex Transm Dis; 1999 Mar; 26(3):137-42. PubMed ID: 10100770
[TBL] [Abstract][Full Text] [Related]
23. The appearance of facial foundation cosmetics applied after metronidazole gel 1%.
Draelos ZD; Colón LE; Preston N; Johnson LA; Gottschalk RW
Cutis; 2011 May; 87(5):251-9. PubMed ID: 21699130
[TBL] [Abstract][Full Text] [Related]
24. Combined effect of anti-inflammatory dose doxycycline (40-mg doxycycline, usp monohydrate controlled-release capsules) and metronidazole topical gel 1% in the treatment of rosacea.
Fowler JF
J Drugs Dermatol; 2007 Jun; 6(6):641-5. PubMed ID: 17668530
[TBL] [Abstract][Full Text] [Related]
25. Interventions for rosacea.
van Zuuren EJ; Fedorowicz Z; Carter B; van der Linden MM; Charland L
Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD003262. PubMed ID: 25919144
[TBL] [Abstract][Full Text] [Related]
26. Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis.
Mimura T; Rizzello F; Helwig U; Poggioli G; Schreiber S; Talbot IC; Nicholls RJ; Gionchetti P; Campieri M; Kamm MA
Aliment Pharmacol Ther; 2002 May; 16(5):909-17. PubMed ID: 11966499
[TBL] [Abstract][Full Text] [Related]
27. Antibacterial essential oils in malodorous cancer patients: clinical observations in 30 patients.
Warnke PH; Sherry E; Russo PA; Açil Y; Wiltfang J; Sivananthan S; Sprengel M; Roldàn JC; Schubert S; Bredee JP; Springer IN
Phytomedicine; 2006 Jul; 13(7):463-7. PubMed ID: 16785038
[TBL] [Abstract][Full Text] [Related]
28. Superiority of ivermectin 1% cream over metronidazole 0·75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial.
Taieb A; Ortonne JP; Ruzicka T; Roszkiewicz J; Berth-Jones J; Peirone MH; Jacovella J;
Br J Dermatol; 2015 Apr; 172(4):1103-10. PubMed ID: 25228137
[TBL] [Abstract][Full Text] [Related]
29. A multicentre, open-label, randomized comparative study of tigecycline versus ceftriaxone sodium plus metronidazole for the treatment of hospitalized subjects with complicated intra-abdominal infections.
Towfigh S; Pasternak J; Poirier A; Leister H; Babinchak T
Clin Microbiol Infect; 2010 Aug; 16(8):1274-81. PubMed ID: 20670293
[TBL] [Abstract][Full Text] [Related]
30. Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea.
Dahl MV; Jarratt M; Kaplan D; Tuley MR; Baker MD
J Am Acad Dermatol; 2001 Nov; 45(5):723-30. PubMed ID: 11606923
[TBL] [Abstract][Full Text] [Related]
31. Pimecrolimus 1% cream, methylprednisolone aceponate 0.1% cream and metronidazole 0.75% gel in the treatment of seborrhoeic dermatitis: a randomized clinical study.
Cicek D; Kandi B; Bakar S; Turgut D
J Dermatolog Treat; 2009; 20(6):344-9. PubMed ID: 19954391
[TBL] [Abstract][Full Text] [Related]
32. The Efficacy and Safety of Topical Dapsone Gel, 5% for the Treatment of Acne Vulgaris in Adult Females With Skin of Color.
Alexis AF; Burgess C; Callender VD; Herzog JL; Roberts WE; Schweiger ES; Stockton TC; Gallagher CJ
J Drugs Dermatol; 2016 Feb; 15(2):197-204. PubMed ID: 26885788
[TBL] [Abstract][Full Text] [Related]
33. Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections in adults.
Yellin AE; Hassett JM; Fernandez A; Geib J; Adeyi B; Woods GL; Teppler H;
Int J Antimicrob Agents; 2002 Sep; 20(3):165-73. PubMed ID: 12385694
[TBL] [Abstract][Full Text] [Related]
34. Metronidazole for a malodorous pressure sore.
Herman J
Practitioner; 1983 Oct; 227(1384):1595-6. PubMed ID: 6634628
[No Abstract] [Full Text] [Related]
35. Metronidazole vaginal gel 1.3% in the treatment of bacterial vaginosis: a dose-ranging study.
Chavoustie SE; Jacobs M; Reisman HA; Waldbaum AS; Levy SF; Hillier SL; Nyirjesy P
J Low Genit Tract Dis; 2015 Apr; 19(2):129-34. PubMed ID: 24983350
[TBL] [Abstract][Full Text] [Related]
36. A Comprehensive Review of Topical Odor-Controlling Treatment Options for Chronic Wounds.
Akhmetova A; Saliev T; Allan IU; Illsley MJ; Nurgozhin T; Mikhalovsky S
J Wound Ostomy Continence Nurs; 2016; 43(6):598-609. PubMed ID: 27684356
[TBL] [Abstract][Full Text] [Related]
37. A systematic review of topical treatments to control the odor of malignant fungating wounds.
da Costa Santos CM; de Mattos Pimenta CA; Nobre MR
J Pain Symptom Manage; 2010 Jun; 39(6):1065-76. PubMed ID: 20538188
[TBL] [Abstract][Full Text] [Related]
38. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of calcipotriene 0.005% foam for the treatment of plaque-type psoriasis: results of two multicenter, randomized, double-blind, vehicle-controlled, phase III clinical trials.
Feldman SR; Matheson R; Bruce S; Grande K; Markowitz O; Kempers S; Brundage T; Wyres M;
Am J Clin Dermatol; 2012 Aug; 13(4):261-71. PubMed ID: 22587791
[TBL] [Abstract][Full Text] [Related]
40. Randomized placebo-controlled trial of metronidazole 1% cream with sunscreen SPF 15 in treatment of rosacea.
Tan JK; Girard C; Krol A; Murray HE; Papp KA; Poulin Y; Chin DA; Jeandupeux D
J Cutan Med Surg; 2002; 6(6):529-34. PubMed ID: 12001006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
